In vivo response to vascular injury in the absence of factor IX: Examination in factor IX knockout mice

Thrombosis Research

Volumn 121, Issue 2, 2007, Pages 225-234

  Gui, Tong ^a,c   Reheman, Adili ^b   Funkhouser, William K ^c   Bellinger, Dwight A ^c   Hagaman, John R ^c   Stafford, Darrel W ^a   Monahan, Paul E ^c   Ni, Heyu ^b,d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Factor IX; Ferric chloride; Hemophilia; Intravital microscopy; Platelet; Vascular injury

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9A; FERRIC CHLORIDE; FIBRINOGEN; THROMBIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CAROTID ARTERY LIGATION; COMPLEX FORMATION; CONTROLLED STUDY; HEMOPHILIA B; HEMOSTASIS; HISTOLOGY; IN VIVO STUDY; MESENTERIC ARTERY; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBUS; WILD TYPE;

ANIMALS; BLOOD VESSELS; CAROTID ARTERY INJURIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FACTOR IX; HEMOPHILIA B; MICE; MICE, KNOCKOUT; PLATELET AGGREGATION; THROMBOSIS;

EID: 36248972253     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.03.026     Document Type: Article

References (41)

1. Lawson J.H., and Mann K.G. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem 266 (1991) 11317-11327
2. Hoffman M., Monroe D.M., Oliver J.A., and Roberts H.R. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 86 (1995) 1794-1801
3. Heemskerk J.W., Kuijpers M.J., Munnix I.C., and Siljander P.R. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med 15 (2005) 86-92
4. Lu G., Broze Jr. G.J., and Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem 279 (2004) 17241-17249
5. Kempton C.L., Hoffman M., Roberts H.R., and Monroe D.M. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol 25 (2005) 861-866
6. Butenas S., Orfeo T., Gissel M.T., Brummel K.E., and Mann K.G. The significance of circulating factor IXa in blood. J Biol Chem 279 (2004) 22875-22882
7. Butenas S., Brummel K.E., Branda R.F., Paradis S.G., and Mann K.G. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 99 (2002) 923-930
8. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22 (2002) 1381-1389
9. Macfarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202 (1964) 498-499
10. Davie E.W., and Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science 145 (1964) 1310-1312
11. Wang X., Cheng Q., Xu L., Feuerstein G.Z., Hsu M.Y., Smith P.L., et al. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 3 (2005) 695-702
12. Renne T., Pozgajova M., Gruner S., Schuh K., Pauer H.U., Burfeind P., et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202 (2005) 271-281
13. Kleinschnitz C., Stoll G., Bendszus M., Schuh K., Pauer H.U., Burfeind P., et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 203 (2006) 513-518
14. Pauer H.U., Renne T., Hemmerlein B., Legler T., Fritzlar S., Adham I., et al. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb Haemost 92 (2004) 503-508
15. Lin H.F., Maeda N., Smithies O., Straight D.L., and Stafford D.W. A coagulation factor IX-knockout mouse model for human hemophilia B. Blood 90 (1997) 3962-3966
16. Chao H., Monahan P.E., Liu Y., Samulski R.J., and Walsh C.E. Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors. Mol Ther 4 (2001) 217-222
17. Lindner V., Fingerle J., and Reidy M.A. Mouse model of arterial injury. Circ Res 73 (1993) 792-796
18. Schwartz R.S., Holmes Jr. D.R., and Topol E.J. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 20 (1992) 1284-1293
19. Ni H., Denis C.V., Subbarao S., Degen J.L., Sato T.N., Hynes R.O., et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106 (2000) 385-392
20. Ni H., Papalia J.M., Degen J.L., and Wagner D.D. Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 102 (2003) 3609-3614
21. Ni H., Ramakrishnan V., Ruggeri Z.M., Papalia J.M., Phillips D.R., and Wagner D.D. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 98 (2001) 368-373
22. Ni H., Yuen P.S., Papalia J.M., Trevithick J.E., Sakai T., Fassler R., et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A 100 (2003) 2415-2419
23. Renne T., Nieswandt B., and Gailani D. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol Dis 36 (2006) 148-151
24. Yamashita A., Nishihira K., Kitazawa T., Yoshihashi K., Soeda T., Esaki K., et al. Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery. J Thromb Haemost 4 (2006) 1496-1501
25. Sudo T., Ito H., and Kimura Y. Genetic strain differences in platelet aggregation of laboratory mice. Thromb Haemost 95 (2006) 159-165
26. Tschopp T.B., Weiss H.J., and Baumgartner H.R. Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med 83 (1974) 296-300
27. Weiss H.J., Tschopp T.B., and Baumgartner H.R. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med 293 (1975) 619-623
28. Bennett J.S., and Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64 (1979) 1393-1401
29. Shirasawa K., Barton B.P., and Chandler A.B. Localization of ferritin-conjugated anti-fibrin-fibrinogen in platelet aggregates produced in vitro. Am J Pathol 66 (1972) 379-406
30. Weiss H.J., and Rogers J. Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med 285 (1971) 369-374
31. Hansen M.S., and Clemmensen I. A fibronectin-binding glycoprotein from human platelet membranes. Biochem J 201 (1982) 629-633
32. Reheman A., Gross P., Yang H., Chen P., Allen D., Leytin V., et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 3 (2005) 875-883
33. Sun W.Y., Witte D.P., Degen J.L., Colbert M.C., Burkart M.C., Holmback K., et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A 95 (1998) 7597-7602
34. Xue J., Wu Q., Westfield L.A., Tuley E.A., Lu D., Zhang Q., et al. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci U S A 95 (1998) 7603-7607
35. Yang H., Reheman A., Chen P., Zhu G., Hynes R.O., Freedman J., et al. Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost 4 (2006) 2230-2237
36. Kung S.H., Hagstrom J.N., Cass D., Tai S.J., Lin H.F., Stafford D.W., et al. Human factor IX corrects the bleeding diathesis of mice with hemophilia B. Blood 91 (1998) 784-790
37. Toomey J.R., Valocik R.E., Koster P.F., Gabriel M.A., McVey M., Hart T.K., et al. Inhibition of factor IX(a) is protective in a rat model of thromboembolic stroke. Stroke 33 (2002) 578-585
38. Choudhri T.F., Hoh B.L., Prestigiacomo C.J., Huang J., Kim L.J., Schmidt A.M., et al. Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage. J Exp Med 190 (1999) 91-99
39. Rusconi C.P., Roberts J.D., Pitoc G.A., Nimjee S.M., White R.R., Quick Jr. G., et al. Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 22 (2004) 1423-1428
40. Nimjee S.M., Keys J.R., Pitoc G.A., Quick G., Rusconi C.P., and Sullenger B.A. A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery. Mol Ther 14 (2006) 408-415
41. Yarovoi H.V., Kufrin D., Eslin D.E., Thornton M.A., Haberichter S.L., Shi Q., et al. Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment. Blood 102 (2003) 4006-4013